RE:RE:Guilty by association I agree with the comments. The market reaction to the RRD and QUAD results were brutal. I think, being a little more nimble, DCM can execute through the challenging environment. Execution on the marketing services (and share gains) will be key to offsetting the organic declines in the base business. I'm expecting >$22 million in EBITDA (excluding changes from IFRS).
At the end of the day, I think one of two things will move the stock (1) capital deployment (which is at least 12 months out given debt repayment is the priority) and/or (2) something cannabis related...
Tough to read how the market will react to the changes from IFRS 16. I expect a decent sized changed to EBITDA (positive) and debt (negative).